tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Simon Baker, 3 are a BUY (18.75%), 7 are a HOLD (43.75%), 6 are a SELL (37.5%).
Analyst Simon Baker, currently employed at REDBURN, carries an average stock price target met ratio of 62.5% that have a potential upside of 14.78% achieved within 388 days. Previously, Simon Baker worked at TD COWEN, SOCGEN.
Simon Baker’s has documented 30 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on MRNA, Moderna at 03-Sep-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 2/1/2022. The price target of $165 was fulfilled within 2 days with a profit of $7.74 (4.48%) receiving and performance score of 22.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Nov-2024
$132
$44.29 (50.50%)
$136
8 days ago
(14-Oct-2026)
0/7 (0%)
$43.34 (48.88%)
Buy Since 11-Mar-2025
$114
$26.29 (29.97%)
$119
15 days ago
(07-Oct-2026)
3/13 (23.08%)
$18.75 (19.69%)
46
Buy Since 05-Sep-2025
$105
$17.29 (19.71%)
$128
1 months 14 days ago
(08-Sep-2026)
0/3 (0%)
$6.34 (6.43%)
Buy Since 08-Aug-2022
$125
$37.29 (42.52%)
$130
2 months 17 days ago
(05-Aug-2026)
0/6 (0%)
$32.82 (35.60%)
Buy Since 04-Aug-2025
$130
$42.29 (48.22%)
$130
2 months 17 days ago
(05-Aug-2026)
4/7 (57.14%)
$37.82 (41.03%)
23
Which stock is Simon Baker most bullish on?
What Year was the first public recommendation made by Simon Baker?
